Chat with us, powered by LiveChat

Parenteral Nutrition Market (Nutrient Type - Carbohydrates, Amino Acids, Lipids, Electrolytes, and Others (Multivitamin Formulations and Trace Elements); Dosage Form - Bags, Vials, Ampules, and Bottles; End User - Clinics, Hospitals, and Others; Patient Type - Pediatrics, and Adults; Disease Type - Alzheimer’s, Cancer Care, Diabetes, Chronic Kidney Diseases, and Others; Distribution Channel - Retail Stores, Pharmacies & Drug Stores, Online Channels, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

Parenteral Nutrition Market (Nutrient Type - Carbohydrates, Amino Acids, Lipids, Electrolytes, and Others (Multivitamin Formulations and Trace Elements); Dosage Form - Bags, Vials, Ampules, and Bottles; End User - Clinics, Hospitals, and Others; Patient Type - Pediatrics, and Adults; Disease Type - Alzheimer’s, Cancer Care, Diabetes, Chronic Kidney Diseases, and Others; Distribution Channel - Retail Stores, Pharmacies & Drug Stores, Online Channels, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

Report Code: IGR01053 Category: Healthcare & Medical Devices Published: March, 2024

A recent report published by Infinium Global Research on parenteral nutrition market provides in-depth analysis of segments and sub-segments in the global as well as regional parenteral nutrition market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional parenteral nutrition market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global parenteral nutrition market.

Market Insight:

The global parenteral nutrition market was valued at USD 6.76 billion in 2022 and is expected to reach USD 11.47 billion in 2030, with a CAGR of 5.96% during the forecast period 2023-2030.

Parenteral nutrition is the intravenous administration of a patient's nutritional solutions. The process involves injecting liquid nutrients into the body through the veins. Parenteral nutrition is typically used to treat medical conditions where a patient's gastrointestinal tract obstruction prevents them from getting sufficient nutrients from meals. This leads to the body receiving inadequate nourishment. Additionally, Parenteral nutrition is primarily intended for patients with cancer, short bowel syndrome, and Crohn's disease. For patients who are unable to obtain enough nutrients orally or internally, it helps prevent malnutrition. There are several commercial therapies and treatments on the market today that are utilized to treat various medical issues. Although these commercially available premixed solutions effectively supply nourishment for short, tailoring parenteral nutrition is the more beneficial method for complex patients.

The increasing prevalence of chronic diseases, gastrointestinal disorders, and malnutrition is a primary driver for the expanding parenteral nutrition market. Increasing market awareness is driven by the benefits of parenteral nutrition in treating patients with reduced gastrointestinal function and reducing nutritional shortages. This increased understanding boosts patients and medical professionals to accept parenteral nutrition as an essential therapeutic option, which supports long-term market expansion and highlights the critical role it plays in managing difficult health issues. Additionally, advancements in healthcare infrastructure and a growing aging population contribute to the heightened demand for parenteral nutrition market. Advances in healthcare enable it possible to diagnose and treat patients more effectively, which makes it easier to integrate parenteral feeding into routine procedures. The demand for efficient nutritional support is increased due to the aging population, which is more likely to suffer from chronic illnesses and have difficulty consuming nutrients orally. The expanding age population and better healthcare capabilities have a double effect that highlights the need for parenteral nutrition to meet a range of patient needs and sustain its market growth. However, limited accessibility and affordability may hinder the widespread adoption of parenteral nutrition. Furthermore, technological advancements and innovation in parenteral nutrition create a lucrative opportunity for growth in the market.

Parenteral Nutrition Market Size, Share, Trends, Analysis | IGR

The North America region holds the largest market share in the global parenteral nutrition market. The development of the region is driven by the presence of technologically advanced medical facilities, a surge in healthcare expenditure, and a rising geriatric population is anticipated to keep North America in the leading position during the forecast period. However, the Asia Pacific region is expected to witness the fastest growth in the parenteral nutrition market during the forecast period. Due to promoting government initiatives for the construction of healthcare infrastructure, developing economies such as China and India are fast expanding. During the forecast period, rising corporate investments in the healthcare sector are also expected to support the growth of the parenteral nutrition market.

Report Scope of the Parenteral Nutrition Market:

Report Coverage Details
Market Size in 2022 USD 6.76 Billion
Market Size by 2030 USD 11.47 Billion
Growth Rate from 2023 to 2030 CAGR of 5.96%
Largest Market North America
No. of Pages 100
Market Drivers
  • The increasing prevalence of chronic diseases, gastrointestinal disorders, and malnutrition is a primary driver for the expanding parenteral nutrition market.

Market Segmentation By Nutrient Type, By Dosage Form, By End User, By Patient Type, By Disease Type, and By Distribution Channel
Regional Scope North America, Europe, Asia Pacific, and RoW

Segment Covered

The report on global parenteral nutrition market covers segments such as nutrient type, dosage form, end user, patient type, disease type, and distribution channel. On the basis of nutrient type, the sub-markets include carbohydrates, amino acids, lipids, electrolytes, and others (multivitamin formulations and trace elements). On the basis of dosage form, the sub-markets include bags, vials, ampules, and bottles. On the basis of end user, the sub-markets include clinics, hospitals, and others. On the basis of patient type, the sub-markets include pediatrics, and adults. On the basis of disease type, the sub-markets include alzheimer’s, cancer care, diabetes, chronic kidney diseases, and others. On the basis of distribution channel, the sub-markets include retail stores, pharmacies & drug stores, online channels, and others.

Companies Profiled:

The report provides profiles of the companies in the market such as B. Braun SE, Fresenius Kabi AG, Allergan/AbbVie, Grifols, S.A., Pfizer Inc., Otsuka Pharmaceutical Factory, Inc., Baxter, Sichuan Kelun Pharmaceutical Co., Ltd., Vifor Pharma Asia Pacific Pte. Ltd., and Aculife.

Report Highlights:

The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the parenteral nutrition market. Moreover, the study highlights current market trends and provides forecasts from 2023-2030. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Frequently Asked Questions (FAQ's)

The global parenteral nutrition market was valued at USD 6.76 Billion in 2022.
It is likely to grow at a CAGR of 5.96% during the forecast period 2023-2030.
The global parenteral nutrition market is estimated to reach USD 11.47 Billion by the end of 2030.
North America is anticipated to exhibit high demand for parenteral nutrition market during the forecast period.
B. Braun SE, Fresenius Kabi AG, Allergan/AbbVie, Grifols, S.A., Pfizer Inc., Otsuka Pharmaceutical Factory, Inc., Baxter, Sichuan Kelun Pharmaceutical Co., Ltd., Vifor Pharma Asia Pacific Pte. Ltd., and Aculife.
CHOOSE LICENCE TYPE

Please Choose One of them.

Google translate
© 2024. Infinium Global Research LLP. All Rights Reserved.